insights_auto
Why is SABS down 4,12%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,79 US$
arrow_downward
-4,12%(-0,12) 1D
20 ნოე, 14:12:41 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
2,79 US$
High
2,88 US$
Low
2,64 US$
Mkt. cap
251,35 მლნ.
Avg. vol.
709,90 ათ.
Volume
410,50 ათ.
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
Open
2,79 US$
High
2,88 US$
Low
2,64 US$
Mkt. cap
251,35 მლნ.
Avg. vol.
709,90 ათ.
Volume
410,50 ათ.
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
News stories
From web sources and news partners
ChartMill
·
1 საათის წინ
S&P 500 Unusual Volume Movers: AES, IBM, ROST, INTU
Barron's
·
35 წუთის წინ
S&P 500’s Tech Sector Crosses Bear Market Threshold
New York Post
·
23 წუთის წინ
S&P 500 and Dow enter correction territory, Nasdaq loses 2026 gains as Anthropic dives
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
Headquartersმაიამი-ბიჩი, ფლორიდა, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitesab.bio